1.505
price up icon5.24%   0.075
 
loading

Finanzdaten der Maxcyte Inc-Aktie (MXCT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
24.66%
7.271
9.651 7.30 6.829 8.507
Cost Of Revenue
6.76%
1.675
1.569 1.61 1.596 1.519
Gross Profit
30.76%
5.596
8.082 5.69 5.233 6.988
Operating Expenses
10.94%
15.83
14.27 16.92 19.38 21.21
Depreciation and Amortization
6.20%
0.953
1.016 1.041 1.044 1.08
Operating Income/Loss
65.43%
-10.23
-6.185 -11.23 -14.15 -14.23
Income/Loss From Continuing Operations Before Tax
86.82%
-8.874
-4.75 -9.596 -12.42 -12.36
Net Income/Loss
86.82%
-8.874
-4.75 -9.596 -12.42 -12.36
Basic Average Shares
0.05%
106.82
106.88 - 106.61 106.40
Diluted Average Shares
0.05%
106.82
106.88 - 106.61 106.40
Basic Earnings Per Share
100.00%
-0.08
-0.04 - -0.12 -0.12
Diluted Earnings Per Share
100.00%
-0.08
-0.04 - -0.12 -0.12
$1.99
price up icon 0.51%
$6.62
price down icon 1.05%
$2.705
price down icon 0.55%
$4.26
price down icon 0.47%
$2.47
price up icon 1.23%
Kapitalisierung:     |  Volumen (24h):